Exome Asset Management LLC Purchases and Sells in Q2 2024

Exome Asset Management LLC

$115 Billion
Q2 2024

Top Buys

Incresed Positions

6 operations

Stock	Shares change	Price Range	Shares Held	Trade History
TGTX	21.3K + 9.25%	$13.32 - $19.19 $284K - $409K	252K $4.48B
MDGL	2.9K + 36.71%	$193.33 - $291.99 $561K - $847K	10.8K $3.03B
TVTX	80.9K + 22.32%	$5.26 - $8.28 $425K - $670K	443K $3.64B
BBIO	30.1K + 61.67%	$23.0 - $31.04 $692K - $934K	78.9K $2B
ZLAB	21.4K + 32.77%	$13.72 - $21.55 $294K - $461K	86.7K $1.5B
DXCM	1.1K + 4.43%	$110.31 - $140.45 $121K - $154K	25.9K $2.94B

New Holdings

27 operations

Stock	Shares change	Price Range	Shares Held	Trade History
MRUS	74K New	$39.81 - $60.2 $2.95M - $4.45M	74K $6.79B
SRPT	32.9K New	$113.33 - $163.85 $3.73M - $5.39M	32.9K $5.2B
WVE	497K New	$4.38 - $6.48 $2.18M - $3.22M	497K $4.41B
AMGN	11.8K New	$262.75 - $319.31 $3.1M - $3.77M	11.8K $3.69B
AVADEL PHARMACEUTICALS PLC	209K New	N/A	209K $2.94B
AUTL	839K New	$3.33 - $5.68 $2.8M - $4.77M	839K $2.92B

Top Sells

Reduced Positions

9 operations

Stock	Shares change	Price Range	Shares Held	Trade History
RDY	-49.7K - 57.79%	$68.26 - $76.19 $3.39M - $3.79M	36.3K $2.77B
CI	-3.1K - 20.26%	$330.57 - $364.08 $1.02M - $1.13M	12.2K $4.03B
VYNE THERAPEUTICS INC	-62K - 14.92%	N/A	353K $696M
Q32 BIO INC	-21.2K - 32.54%	N/A	43.9K $787M
SAGIMET BIOSCIENCES INC	-10.2K - 16.75%	N/A	50.7K $173M
IMAB	-54.4K - 16.69%	$1.58 - $1.9 $85.9K - $103K	271K $453M

Activity Summary All Purchases 33 New Holdings 27 Increased Positions 6 All Sells 9 Reductions 9 Sold out 0 Calls 0 Puts 0

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exome Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exome Asset Management LLC with notifications on news.